
Globalization strikes back after COVID carnage
A nondescript German biotech firm founded by scientists with Turkish heritage attracts investment from a Chinese conglomerate and joins hands with a US pharmaceutical behemoth helmed by a Greek chief executive. The companies source a key raw material from …